These studies – a clinical trial demonstrating Peptan’s efficacy in improving skin beauty markers and a bioavailability study showcasing its effective absorption profile – provide valuable scientific insights for the nutraceutical and functional food industries. The findings will be showcased at Vitafoods Asia in Bangkok, September 18-20, 2024.

Published in the Wiley Journal of Cosmetic Dermatology, the clinical study by Vleminckx et al. investigated the influence of Peptan collagen peptide supplementation on visible signs of skin beauty and aging in East Asian women aged 40-65. The trial, involving 85 participants who took 5g of Peptan daily for 12 weeks, showed significant improvements compared to the placebo group: skin density, elasticity, and hydration increased while wrinkle depth was reduced.(1)

“This study solidifies Peptan’s robust scientific foundation as a powerful ingredient for delivering evidence-based beauty solutions globally, including in Asia,” said Gaëtan Noiret, Global Director of Health & Nutrition at Rousselot.

In a second study, published in Frontiers in Nutrition, researchers from Rousselot, BioTeSys and Triskelion conducted a randomized, double-blind crossover trial to explore Peptan’s absorption profile. The study evaluated the absorption of bioactive di- and tri- peptides and free amino acids – key markers of collagen intake – from bovine hide, porcine skin and fish skin each with varying molecular weights, following consumption by healthy individuals. By measuring plasma concentrations of free and peptide-bound hydroxyproline (Hyp), results showed significant levels of these metabolites.(2) Importantly, the findings indicated consistent bioavailability – defined as the portion of a nutrient or bioactive compound that can be absorbed into the bloodstream(3) – across different raw material sources and molecular weights.

“These findings further affirm Peptan’s value as an effective and bioavailable ingredient, regardless of its origin or molecular weight, underscoring its versatility for use in a wide range of product applications,” Noiret said.

Rousselot will present these groundbreaking studies at Vitafoods Asia 2024. Catarina da Silva, Rousselot’s Science Integration Manager, will discuss the findings and their implications for beauty-from-within applications and holistic well-being. Visitors can learn more about Peptan and these recent studies by visiting the Rousselot booth P10 during the event or the website www.rousselot.com.

 


(1) Vleminckx, S., et al, Influence of collagen peptide supplementation on visible signs of skin and nail health and aging in an East Asian population: a double blind, randomized, placebo-controlled trial, Journal of Cosmetic Dermatology, 2024;00:1–9, https://doi.org/10.1111/jocd.16458.

(2) Virgilio, N., et al., Absorption of bioactive peptides following collagen hydrolysate intake: A randomized, double-blind crossover study in healthy individuals, Frontiers in Nutrition, 11, 1416643, 2024. https://pubmed.ncbi.nlm.nih.gov/39149544/ 

(3) Ibid


­Rousselot makes no representation or warranty, whether expressed or implied, as to the accuracy, reliability, or completeness of the information, nor does it assume any legal liability, whether direct or indirect, for any information. Use of this information shall be at your discretion and risk. Nothing herein relieves you from carrying out your own suitability determinations and tests and from your obligation to comply with all applicable laws and regulations and to observe all third-party rights. This product is not intended to diagnose, treat, cure, or prevent any disease.